Literature DB >> 15221550

Second primary digestive cancer after resection of lung cancer.

Hidenori Kamiyama1, Tomohiko Ikeya, Kazuharu Suda, Katsumi Murai, Katsuhiko Aoyama, Eishin Hoshi.   

Abstract

PURPOSE: We evaluated the clinical findings of patients with second primary digestive cancers (SPDC) after the resection of lung cancer.
METHODS: Among 772 patients who underwent resection of primary lung cancer at Saitama Cardiovascular and Respiratory Center between 1993 and 2002, 10 (1.3%) were diagnosed with SPDC during follow-up. These ten patients were classified into two groups based on whether the SPDC was incidentally (group I) or symptomatically (group S) diagnosed.
RESULTS: The median interval to the detection of SPDC was 17 months in group I and 66 months in group S, and the disease was at an earlier stage in group I than in group S ( P = 0.008). Comparing body weight at the time of lung resection to that at the time of abdominal surgery, significant weight loss was evident in group S ( P = 0.009). The postoperative disease-specific survival rate was 100% in group I. No long-term survivor died of lung cancer.
CONCLUSION: Special attention must be paid to the possibility of SPDC after the resection of lung cancer to improve the prognosis of patients with lung cancer.

Entities:  

Mesh:

Year:  2004        PMID: 15221550     DOI: 10.1007/s00595-004-2762-0

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  2 in total

1.  Concurrent Tumors Revealed by an Autopsy-A Case Report and Literature Review.

Authors:  Miruna Cristian; Mădălina Boșoteanu; Mariana Așchie; Angelica Potamian; Cătălin Adrian Boșoteanu; Gabriela Izabela Bălțătescu
Journal:  Case Rep Gastrointest Med       Date:  2022-06-01

2.  Clinicopathological features and the impact of the new TNM classification of malignant tumors in patients with pulmonary large cell neuroendocrine carcinoma.

Authors:  Akira Iyoda; Shi-Xu Jiang; William D Travis; Naomi Kurouzu; Fumihiro Ogawa; Hideki Amano; Yuichi Sato; Valerie W Rusch; Makoto Saegusa; Yukitoshi Satoh
Journal:  Mol Clin Oncol       Date:  2013-02-28
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.